All In MedTech

Device Trial Radar · NCT00853632

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Carpentier-Edwards® Perimount Magna® Mitral Pericardial Bioprostheses Models 7000/7000 TFX and Carpentier-Edwards® Perimount Magna® Mitral Ease™ Pericardial Bioprostheses Models 7200TFX and 7300/7300TFX

Last checked: Nov 20, 2026Latest source record: May 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

329

Actual

Start

Aug 2007

Primary completion

Mar 6, 2024

Study completion Mar 6, 2024

Sponsor

Lead sponsor
Edwards LifesciencesPublic (EW)
Sponsor type
Industry
First posted
Mar 2, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to demonstrate the long term safety and effectiveness of the Carpentier-Edwards® PERIMOUNT Magna Mitral Valves in patients undergoing mitral valve replacement with or without concomitant procedures requiring cardiopulmonary bypass.

Conditions

  • Coronary Artery Disease
  • Mitral Valve Regurgitation
  • Mitral Valve Incompetence
  • Heart Failure

Interventions

  • CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESESDevice

    Mitral valve replacement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Subject's Rate of Objective Performance Criteria Per ISO 5840-2005 - Total Number of Late Adverse Events (by Category) Divided by Late Patient Years (Expressed as a Percentage) for the Magna Mitral Valve Implanted CohortTime frame: Events occurring ≥ 31 days and up through 8 years post-implant
  2. Primary Effectiveness EndpointsTime frame: 8 years post-implant

Locations

15 sites in 4 countries. Site status is shown where the registry gives one.

  • Dignity Health Research Institute

    Sacramento, California

  • AdventHealth Orlando

    Orlando, Florida

  • Northwestern University Hospital

    Chicago, Illinois

12 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.